Albert S. Baldwin
University of North Carolina at Chapel Hill · 404 works · 51,748 citations · h-index 104
Top works
- THE NF-κB AND IκB PROTEINS: New Discoveries and Insights
- TNF- and Cancer Therapy-Induced Apoptosis: Potentiation by Inhibition of NF-κB
- Characterization of an immediate-early gene induced in adherent monocytes that encodes IκB-like activity
- Tumor necrosis factor and interleukin-1 lead to phosphorylation and loss of I kappa B alpha: a mechanism for NF-kappa B activation.
- Molecular cloning of an enhancer binding protein:Isolation by screening of an expression library with a recognition site DNA
- NF-κB Antiapoptosis: Induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to Suppress Caspase-8 Activation
- The I kappa B proteins: multifunctional regulators of Rel/NF-kappa B transcription factors.
- Role of Transcriptional Activation of IκBα in Mediation of Immunosuppression by Glucocorticoids
- I kappa B interacts with the nuclear localization sequences of the subunits of NF-kappa B: a mechanism for cytoplasmic retention.
- Binding of a nuclear factor to a regulatory sequence in the promoter of the mouse H-2Kb class I major histocompatibility gene.
- Two transcription factors, NF-kappa B and H2TF1, interact with a single regulatory sequence in the class I major histocompatibility complex promoter.
- Human CCAAT-binding proteins have heterologous subunits
- Regulation of heat shock protein 70 gene expression by c-myc
- Control of oncogenesis and cancer therapy resistance by the transcription factor NF-κB
- Cross‐coupling of the NF‐kappa B p65 and Fos/Jun transcription factors produces potentiated biological function.
- Transcription Control by Oncogenes
- Characterization of Mechanisms Involved in Transrepression of NF-κB by Activated Glucocorticoid Receptors
- Inducible phosphorylation of I kappa B alpha is not sufficient for its dissociation from NF-kappa B and is inhibited by protease inhibitors.
- Requirement of NF-κB Activation to Suppress p53-Independent Apoptosis Induced by Oncogenic Ras
- Control of inducible chemoresistance: Enhanced anti-tumor therapy through increased apoptosis by inhibition of NF-κB